What is a stock summary page? Click here for an overview.
New Key Statistics Module, Z-Score and F-Score
NAS:CYTK Key Ratios
Market Cap $ M | 4,818.76 |
Enterprise Value $ M | 4,519.50 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | 257.48 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 18.00 |
EPS (TTM) $ | -5.26 |
Beneish M-Score | 3.51 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -30.20 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -8.98 |
EV-to-EBITDA | -9.16 |
PEG | -- |
Shares Outstanding M | 119.19 |
Net Margin (%) | -3,191.11 |
Operating Margin % | -2,902.72 |
Pre-tax Margin (%) | -3,191.11 |
Quick Ratio | 6.17 |
Current Ratio | 6.17 |
ROA % (ttm) | -49.18 |
ROE % (ttm) | -- |
ROIC % (ttm) | -138.11 |
Dividend Yield % | -- |
Altman Z-Score | -1.20 |
CYTK Number of Guru Trades
CYTK Volume of Guru Trades
Gurus Latest Trades with NAS:CYTK
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CYTK is held by these investors
Total 3
Cytokinetics Inc Insider Transactions
No Available Data
News about NAS:CYTK
Total 0- 1